Mark Berger - Sep 27, 2021 Form 4 Insider Report for Genprex, Inc. (GNPX)

Role
Chief Medical Officer
Signature
/s/ Ryan Confer as Attorney-In-Fact for Mark S. Berger
Stock symbol
GNPX
Transactions as of
Sep 27, 2021
Transactions value $
$0
Form type
4
Date filed
9/28/2021, 04:26 PM
Previous filing
Sep 3, 2021
Next filing
Feb 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNPX Stock Option (right to buy) Award $0 +550K $0.00 550K Sep 27, 2021 Common Stock 550K $2.85 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted outside of the Registrant's incentive award plans as an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4).
F2 One-third of the options will vest on each of the first, second and third anniversaries of the date on which the Reporting Person commences employment with the Registrant.